First National Bank of Mount Dora Trust Investment Services bought a new position in The Allstate Co. (NYSE:ALL - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 14,308 shares of the insurance provider's stock, valued at approximately $2,963,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Allstate by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 32,635,424 shares of the insurance provider's stock worth $6,291,783,000 after acquiring an additional 389,426 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Allstate by 2.4% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,334,926 shares of the insurance provider's stock worth $1,799,681,000 after purchasing an additional 218,771 shares during the period. Bank of America Corp DE boosted its stake in shares of Allstate by 157.9% during the fourth quarter. Bank of America Corp DE now owns 6,591,138 shares of the insurance provider's stock valued at $1,270,705,000 after purchasing an additional 4,035,629 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Allstate by 3.1% during the fourth quarter. Geode Capital Management LLC now owns 6,419,728 shares of the insurance provider's stock worth $1,236,060,000 after buying an additional 191,147 shares during the period. Finally, GQG Partners LLC grew its stake in Allstate by 64.1% in the fourth quarter. GQG Partners LLC now owns 4,316,516 shares of the insurance provider's stock valued at $832,181,000 after purchasing an additional 1,685,694 shares during the last quarter. Institutional investors own 76.47% of the company's stock.
Analyst Upgrades and Downgrades
ALL has been the topic of a number of analyst reports. Keefe, Bruyette & Woods lifted their price objective on shares of Allstate from $228.00 to $235.00 and gave the stock an "outperform" rating in a research report on Wednesday, May 7th. Barclays reduced their target price on Allstate from $183.00 to $172.00 and set an "underweight" rating on the stock in a research report on Friday, April 11th. Morgan Stanley increased their price target on Allstate from $225.00 to $235.00 and gave the company an "overweight" rating in a research note on Tuesday, May 6th. Evercore ISI boosted their price target on Allstate from $227.00 to $230.00 and gave the stock an "outperform" rating in a research note on Thursday, May 1st. Finally, Wall Street Zen raised shares of Allstate from a "hold" rating to a "buy" rating in a research report on Thursday, May 1st. One research analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Allstate currently has an average rating of "Moderate Buy" and a consensus target price of $225.20.
Get Our Latest Stock Report on ALL
Allstate Stock Performance
Shares of Allstate stock traded down $0.79 during trading on Wednesday, hitting $195.61. 616,533 shares of the company's stock were exchanged, compared to its average volume of 1,610,008. The stock has a market capitalization of $51.80 billion, a price-to-earnings ratio of 11.52, a PEG ratio of 1.01 and a beta of 0.35. The business has a 50-day simple moving average of $199.31 and a 200-day simple moving average of $197.09. The Allstate Co. has a 52-week low of $156.66 and a 52-week high of $213.18. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.98 by ($0.45). Allstate had a net margin of 7.28% and a return on equity of 28.20%. The company had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. During the same period last year, the firm earned $5.13 EPS. The business's quarterly revenue was up 7.8% compared to the same quarter last year. On average, research analysts forecast that The Allstate Co. will post 18.74 EPS for the current year.
Allstate Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 9th will be issued a $1.00 dividend. The ex-dividend date is Monday, June 9th. This represents a $4.00 dividend on an annualized basis and a yield of 2.04%. Allstate's payout ratio is 27.32%.
Allstate announced that its board has initiated a share repurchase plan on Wednesday, February 26th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the insurance provider to buy up to 3% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board believes its shares are undervalued.
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.